In gastric cancer (GC) and esophagogastric junction cancer (EGJC), immunohistochemistry (IHC) 3 + or IHC 2 + in situ hybridization-positivity indicate HER2-positivity [4, 5]. This evidence concerns the gene ERBB2 and gastric cancer.